BMO Capital Recommends CSX (CSX) Stock to 'Patient Value Investors'; PT Lowered
Tweet Send to a Friend
BMO Capital analyst Fadi Chamoun lowered the price target on CSX (NASDAQ: CSX) to $35.00 (from $36.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
